… The antiphospholipid syndrome (APS) is characterized clinically by the presence of venous
… a prospective analysis of clinical and analytical findings in individuals with antiphospholipid …

… To answer some of the questions about the relationship between antiphospholipid antibodies
and the clinical manifestations, activity, and treatment of SLE, we began a prospective …

… Antiphospholipid syndrome (APS) is an autoimmune disease characterized … Antiphospholipid
syndrome (APS) is an autoimmune disease characterized by persistent antiphospholipid …

… antiphospholipid syndrome (APS) and to compare them with patients with positive
antiphospholipid … (b) To analyze the association of vitD levels with both the clinical manifestations …

… Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid
syndrome (APS) during a 5-year period and to determine clinical and immunological …

… The antiphospholipid syndrome (APS) is a systemic autoimmune disorder where different
prothrombotic factors interact to induce arterial and venous thrombosis.1 It is defined by a …

… individually and in combination with criteria anti-phospholipid (aPL) tests in a prospectively
ascertained cohort of patients at risk for anti-phospholipid syndrome (APS). One hundred …

… Some prospective studies have likewise failed to produce reliable results since patients with
vascular antiphospholipid syndrome (APS) and carriers of aPL were considered together.16,…

… are frequently observed in primary antiphospholipid syndrome (PAPS), … prospectively
studied for 5 years. The preliminary Sapporo classification criteria for antiphospholipid syndrome (…

… Antiphospholipid Syndrome (APS) patients. There is only one randomized controlled trial
published while others are still ongoing. Many non-randomized studies have been published …